ArticleJournal of pharmaceutical health care and sciences2022

Immune checkpoint inhibitor therapy and elevated levels of C-reactive protein associated with COVID-19 aggravation in patients with lung cancer.

Masatoshi Maki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.